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Background: Satellite cells are resident skeletal muscle stem cells responsible for muscle maintenance and repair.
In resting muscle, satellite cells are maintained in a quiescent state. Satellite cell activation induces the myogenic
commitment factor, MyoD, and cell cycle entry to facilitate transition to a population of proliferating myoblasts that
eventually exit the cycle and regenerate muscle tissue. The molecular mechanism involved in the transition of a
quiescent satellite cell to a transit-amplifying myoblast is poorly understood.
Methods: Satellite cells isolated by FACS from uninjured skeletal muscle and 12 h post-muscle injury from wild
type and Syndecan-4 null mice were probed using Affymetrix 430v2 gene chips and analyzed by Spotfiretm and
Ingenuity Pathway analysis to identify gene expression changes and networks associated with satellite cell
activation, respectively. Additional analyses of target genes identify miRNAs exhibiting dynamic changes in
expression during satellite cell activation. The function of the miRNAs was assessed using miRIDIAN hairpin
inhibitors.
Results: An unbiased gene expression screen identified over 4,000 genes differentially expressed in satellite cells
in vivo within 12 h following muscle damage and more than 50% of these decrease dramatically. RNA binding
proteins and genes involved in post-transcriptional regulation were significantly over-represented whereas splicing
factors were preferentially downregulated and mRNA stability genes preferentially upregulated. Furthermore,
six computationally identified miRNAs demonstrated novel expression through muscle regeneration and in satellite
cells. Three of the six miRNAs were found to regulate satellite cell fate.
Conclusions: The quiescent satellite cell is actively maintained in a state poised to activate in response to external
signals. Satellite cell activation appears to be regulated by post-transcriptional gene regulation.
Keywords: Satellite cell, RNA post-transcriptional regulation, microRNA.Background
Skeletal muscle is terminally differentiated and thus, requires
a population of resident adult stem cells, satellite cells, for
maintenance and repair [1-3]. Satellite cells are typically
mitotically quiescent in resting muscle and activate to pre-
pare for cell cycle entry by HGF [4,5], nitric oxide [6], and
TNFα [7], upon a muscle injury. Intracellular p38α/βMAPK
and downstream signaling is stimulated upon satellite cell
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reproduction in any medium, provided the orphase entry [8,9], and subsequent proliferation. A subset of
satellite cells self-renew to maintain the satellite cell pool
(Troy et al.)a [10,11] and generate a rapidly proliferating
transit-amplifying myoblast population (Troy et al.)a [10].
The transition from a quiescent satellite cell to a prolifer-
ating, transit amplifying myoblast was thought to require
extensive transcriptional induction as quiescent satellite
cells have a low ratio of cytoplasmic volume to nuclear vol-
ume, few cellular organelles, tightly packed heterochroma-
tin, and are believed to be metabolically inactive [12,13].
However, recent evidence suggests that satellite cell quies-
cence is ‘active’ and satellite cells are poised to react to ex-
ternal stimuli after muscle damage [14]. Moreover,
quiescent fibroblasts exhibit high metabolic activity [15] intd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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Interestingly, a growing pool of data demonstrates that cell
fate determination is reliant on post-transcriptional gene
regulation [16-20] and may provide mechanisms to main-
tain quiescent satellite cells in a ready state.
One such RNA post-transcriptional mechanism,
microRNA-mediated gene silencing, regulates skeletal
muscle specification and myogenic differentiation [21-23].
MicroRNAs (miRNA) are a class of small non-coding
RNAs that bind to target mRNA in a sequence specific
manner to mediate gene silencing [24-27] and can target
and silence protein expression from tens to hundreds of
mRNAs [26,27]. Furthermore, miRNAs modulate stem
cell fate decisions [28-31] and may have similar functions
in satellite cells. Recent studies identify miR-489 and
miR-206 expression in quiescent satellite cells [32,33],
however, it is likely that many uncharacterized miRNAs
play roles in the transition of a quiescent satellite cell to
transit-amplifying myoblast.
To understand the mechanisms involved in satellite cell
activation, we previously screened a number of candidate
genes for changes in expression from freshly isolated
satellite cells and from satellite cells isolated at either 12 h
post-muscle injury or 48 h post-muscle injury to represent
quiescent, activated, and proliferating satellite cells, re-
spectively. Although unbiased gene expression screens
have been performed on satellite cells, these studies have
either compared freshly isolated satellite cells to satellite
cells expanded in culture [14,34] or to satellite cells in dis-
eased skeletal muscle [14]. Neither of these studies directly
compared satellite cells prior to and following induced
muscle injury in vivo and thus, the reported gene expres-
sion changes specific to cell culture or specific to diseased
muscle may not reliably identify gene expression changes
associated with satellite cell activation in vivo. Here, we re-
port global gene expression profiles and candidate miRNAs
associated with quiescent and activated satellite cells as
well as identify a novel function for miR-16, miR-106b, and
miR-124 in satellite cell fate determination. From these
analyses, we posit that satellite cell activation is primar-
ily regulated by post-transcriptional gene regulation as
opposed to transcriptional induction.
Methods
Mice
All animal procedures were performed according to proto-
col number 1012.01 approved by Institutional Animal Care
and Use Committee at the University of Colorado at Boul-
der. Mice were housed in a pathogen-free environment at
the University of Colorado at Boulder. All mice sacrificed
were female and between 3 and 6 months of age. Wild type
mice were C57Bl/6xDBA2 (B6D2F1/J, Jackson Labs)
and syndecan-4−/− mice carry homozygous deletion of
syndecan-4 in the C57Bl/6 background [35].Fluorescence-activated cell sorting of satellite cells
The tibialis anterior muscles of 3-month-old female
B6D2F1/J or syndecan-4−/− mice were injured by injection
with 50 μL 1.2% BaCl2 in saline prior to harvest or har-
vested from uninjured hind limbs. The tibialis anterior
muscles were dissected from the hind limb, minced, and
digested in 400 U/mL collagenase in Ham’s F-12C at 37°C
for 1 h, vortexing frequently. Collagenase was inactivated
by the addition of horse serum and debris was removed by
sequential straining through 70 μm and 40 μm cell strai-
ners (BD Falcon). Cells were gently centrifuged and the cell
pellets were incubated at 4°C with 1:100 rabbit anti-
syndecan-3 antibody in Ham’s F-12C with 15% horse
serum followed by an incubation on ice with Cy5 conju-
gated anti-rabbit-IgG (Molecular Probes). Satellite cells
were sorted based on syndecan-3 immunoreactivity on a
MoFlo Legacy cell sorter (Dako Cytomation) directly into
RNA lysis buffer (PicoPure RNA Isolation kit, Arcturus).
Myofiber explant culture and immunostaining
All hind limb muscles were dissected, connective tissue
removed, and individual muscle groups isolated followed
by digestion in 400 U/mL collagenase in Ham’s F-12C at
37°C. Single myofibers were isolated and grown in Ham’s
F-12C supplemented with 15% horse serum and 0.5 nM
FGF-2 prior to fixation in 4% PFA. Fibers were blocked in
10% normal goat serum in phosphate buffered saline fol-
lowed by antibody staining. Primary antibodies were rabbit
anti-cmet (Santa Cruz) at 1:100, mouse anti-MyoD (Novo-
castra) at 1:10, mouse anti-Pax7 at 1:5 (Developmental
Studies Hybridoma Bank), and rabbit anti-MyoD C-20 at
1:500 (Santa Cruz Biotechnology). Secondary antibodies
were Alexa-488 conjugated anti-mouse IgG, Alexa-594
conjugated anti-rabbit IgG, Alexa-555 conjugated anti-
mouse IgG, and Alexa-647 conjugated anti-rabbit IgG
(Molecular Probes). All images taken on a Nikon Eclipse
E800 microscope with a Nikon 40x/0.75 differential inter-
ference contrast M lens and analyzed with Slidebook (In-
telligent Imaging Innovations, Inc.).
Microarray hybridization
RNA was isolated from satellite cells using the PicoPure
RNA Isolation kit (Arcturus) followed by two rounds of
linear T7-based amplification (RiboAmp HA kit: Arcturus).
The RNA equivalent of 5,000 cells was hybridized to Affy-
metrix mouse 430v2 GeneGhips (MOE430v2) according to
manufacturer’s instructions. GeneChips were scanned at
the University of Colorado at Boulder on an Affymetrix
GeneChip Scanner 3000 and spot intensities were recov-
ered in the GeneChip Operating System (Affymetrix).
Microarray data processing and analysis
All analysis was performed using SpotfireTM DecisionSite
2 for Microarray Analysis. The raw CEL data files were
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(GCRMA). The raw CEL data files, microarray metadata,
and GCRMA normalized expression values were depos-
ited in GEO datasets (GSE38870). One wild type freshly
isolated satellite cell replicate consistently clustered with
the wild type satellite cells 12 h post-injury replicates
(via hierarchical, Self-Organizing Map (SOM), k-means)
indicating myogenic commitment and was removed
from our analysis. The hierarchical cluster and asso-
ciated dendrogram were generated using the log2-valueTable 1 Quantitive PCR primer sequences
Gene Primer type Sequence
GAPDH Forward 5’ - TGTGTCCGTCGTGGATCTGA - 3’
Reverse 5’ - CCTGCTTCACCACCTTCTTGA - 3’
18S Forward 5’ - GCCGCTAGAGGTGAAATTCTTG - 3’
Reverse 5’ - CTTTCGCTCTGGTCCGTCTT - 3’
Celf4 Forward 5’ CCTGCTCATCTACCATCTGCC - 3’
Reverse 5’ - GCTCACGAAGCCAAAGCATTT - 3’
Pabpn1 Forward 5’ - TTTCCTTGCCCTGTTTCCCATGTC - 3’
Reverse 5’ - AGTGACTGAAGGGAGCACCTCAAA - 3’
Ppargc1a Forward 5’ - TAGTTTGAGCCCTTGCTGGCTCTT - 3’
Reverse 5’ - AGCTCAGTGAGGCTGATGTGTACT - 3’
Mbnl1 Forward 5’ - AACTGGACAGAACCGGGAAGAACT - 3’
Reverse 5’ - GCAAACTGCAACTTGTGACACGGA - 3’
Matr3 Forward 5’ - ATTGTGGATAGGGCCAGTCATGGT - 3’
Reverse 5’ - TTGCATTTGAGACAAGTGGCCTGG - 3’
Sfrs3 Forward 5’ - TGTGGCACTGTGGGTGGAATGATA - 3’
Reverse 5’ - CTGAAAGGACACTGGCATCTGAGT - 3’
Zfp36 Forward 5’ - TCTCTGCCATCTACGAGAGCC - 3’
Reverse 5’ - CCAGTCAGGCGAGAGGTGA - 3’
Zfp36l1 Forward 5’ - GCTTTCGAGACCGCTCTTTCT - 3’
Reverse 5’ - TTGTCCCCGTACTTACAGGCA - 3’
Zfp36l2 Forward 5’ - AGCGGCTCCCAGATCAACT - 3’
Reverse 5’ - CGAAAGCGAAGGCGTTGTTA - 3’
Elavl1 Forward 5’ - TGTGAGTCACCAGCTGCCAAGTAT - 3’
Reverse 5’ - GAGGTGGTTCAAACCAACCAACCA - 3’
Cdk2 Forward 5’ - TCCTCTGAGAGCAGTGATGCA - 3’
Reverse 5’ - TTCCCCCAATGACCTAACCAG - 3’
E2F3 Forward 5’ - GGTCCTGGATCTGAACAAGGC - 3’
Reverse 5’ - CCTTCCAGCACGTTGGTGAT - 3’
U6 Reverse 5’ - AATTCGTGAAGCGTTCCATAT - 3’
miR-16 Reverse 5’ - TAGCAGCACGTAAATATTGGCG - 3’
miR-93 Reverse 5’ - CAAAGTGCTGTTCGTGCAGGTAG - 3’
miR-106b Reverse 5’ - TAAAGTGCTGACAGTGCAGAT - 3’
miR-107 Reverse 5’ - AGCAGCATTGTACAGGGCTATCA - 3’
miR-124 Reverse 5’ - TAAGGCACGCGGTGAATGCC - 3’
miR-200b Reverse 5’ - TAATACTGCCTGGTAATGATGA - 3’
Sequences for forward and reverse primers used to detect mRNAs or
sequence of reverse primer used to detect miRNAs using the Ncode universal
forward primer.for relative probe intensity using the Unweighted Pair
Group Method with Arithmetic Mean (UPGMA) with
Euclidean distance as the similarity measure. The signifi-
cance between genotypes and time points was deter-
mined using the multifactor analysis of variance
(ANOVA) with a false discovery rate (FDR) ≤ 0.05 and
Bonferroni adjustment. Fold change was calculated as
2abs(difference), where difference is the log2 difference be-
tween samples compared. Venn diagrams were gener-
ated in SpotfireTM using the list comparison function.
Gene ontology and biological pathway analysis
Unique gene identifiers (gene symbol, entrez gene ID, or
Affymetrix probeset ID) were uploaded to the Database
for Annotation, Visualization and Integrated Discovery
(DAVID http://david.abcc.ncifcrf.gov/), FunNet (http://
www.funnet.info/), and ProfCom (http://webclu.bio.wzw.
tum.de/profcom/). The mouse genome reference dataset
for each algorithm was used as background. No further
settings were required for DAVID. Analysis setting for
FunNet were conventional functional analysis with the
specificity enrichment computation for GO and false
discovery rate ≤ 5%. Analysis settings for ProfCom were
up degree 1 and exclude. The default settings for each
algorithm were used to identify enriched GO terms.
Affymetrix probeset IDs and the log2 difference between
wild type freshly isolated satellite cells and satellite cells
isolated 12 h post-injury were uploaded and analyzed
using IPA v9.0 (IngenuityW Systems www.ingenuity.
com). Analysis settings were to consider both all direct
and indirect molecules and/or relationships using the
Mouse Genome 430 2.0 Array as a reference dataset.
Computational prediction of miRNAs
The Srivastava lab algorithm assessed mRNA sequences
in human, mouse, and rat for miRNA seed matches and
required base-paring of miRNA nucleotides 2 to 7 with
binding energy ≤ −14 kcal/mol and flanking energy ≥−7
kcal/mol. Secondary structure was used to eliminate
false-positives by removing those seed matches with
secondary elements that stabilize mRNA. Priority 1 calls
had a destabilizing mRNA element while Priority 2 calls
did not contain a destabilizing element in at least one
species. GeneAct used the miRanda algorithm to identify
miRNA target sites across three mammalian species.
False-positives were eliminated with the differential bind-
ing site search against genes that were constitutively
expressed in satellite cells.
RNA isolation
mRNA was extracted from satellite cells using the RNeasy
Kit according to the manufacturer’s protocol (Qiagen).
miRNA was extracted using both the RNAqueous-micro
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Figure 1 Sdc4−/− satellite cell gene expression post-muscle injury is similar to freshly isolated satellite cells. Myofiber-associated satellite
cells are immunoreactive for MyoD 24 h and 48 h after isolation from wild type mice but not Sdc4−/− mice (A, B). Wild type but not Sdc4−/−
cells divide by 48 h in culture (B) where c-met (red), MyoD (green), and DAPI (blue) identify satellite cells and a dashed line indicates the position
of the myofiber membrane (A, B). Flow cytometry histograms of wild type (C) and syndecan-4 null (D) mononuclear cells from uninjured and
injured skeletal muscle 12 h and 48 h post-injury plotted for cell size (FSC) vs. internal complexity (SSC), where the red box indicates gating for
further analysis to remove debris (upper panels). Syndecan-3 immunoreactive cells present in the gate were isolated from wild type mice
(C, lower panel) and Sdc4−/− mice (D, lower panel) where the percentages indicate satellite cells (blue lines) relative to other events with
false-positives set to an antibody background< 0.1% (red lines). A hierarchical dendrogram constructed with SpotfireTM DecisionSite using
Affymetrix GeneChip data reveals that Sdc4−/− satellite cells cluster most closely to freshly isolated wild type satellite cells while injured wild type
satellite cells either 12 h post-injury or 48 h post-injury cluster independently (E). Red depicts high relative gene expression and green depicts
low relative expression in the hierarchical cluster dendrograms (UPGMA, Euclidean distance). FI, freshly isolated; PI, post-injury.
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modifications. For satellite cells, the mirVana manufac-
turer’s protocol was followed using volumes and columns
for the RNAqueous-micro kit. For MM14 cells, the mir-
Vana manufacturer’s protocol was followed. RNA concen-
tration was determined using a NanoDrop 2000
spectrophotometer (Thermo Scientific).
Quantitative RT-PCR
The Superscript III First Strand cDNA Synthesis kit was
used to generate cDNA from mRNA according to manu-
facturer’s instructions (Invitrogen). The Ncode miRNA
qRT-PCR system (Invitrogen) was used to generate
cDNA from miRNA according to manufacturer’s instruc-
tions. Briefly, RNA was poly-adenylated with Poly-A
polymerase followed by cDNA transcription with Super-
script III reverse transcriptase using a primer similar to



































































Figure 2 Gene expression changes occurring during satellite cell activ
satellite cells and satellite cells isolated 12 h post-injury from wild type and
unique to wild type satellite cells (A, yellow, ANOVA P≤ 0.01, ≥ two-fold ch
unique to wild type satellite cells with more than half (56%) of the transcri
(B, red is high relative expression and green low relative expression). The fr
significantly higher than the frequency of genes that increase (□) more tha
analysis of gene expression data using IPA 9.0 (IngenuityW Systems, www.in
progression increase (green) while genes that inhibit the G1/S phase transi
(D, relative intensity depicts the fold change with higher color intensity deperformed using SYBR-Green (Applied Biosystems) or
SYBR-GreenER (Invitrogen) on either an ABI 7500 Fast
or ABI 7900 Real-Time PCR machine (Applied Biosys-
tems). Primer sequences are listed in Table 1.
RNase protection assay
Candidate miRNAs were screened using the mirVana
miRNA detection kit according to the manufacturer’s
protocol (Ambion). All probes were radio-labeled with
32P-UTP using the mirVana miRNA probe construction
kit (Ambion) according to manufacturer’s protocol.
Isolation of quiescent satellite cells
Quiescent satellite cells were isolated following IP injec-
tion with 75 mg/kg of SB203580 (Alexis Corporation)
and kept in 25 μM SB203580 through the isolation as
described (Hausburg et al., Submitted). All satellite cells
were isolated as follows. Hind limb muscles of 3- toFold Change
upregulated
downregulated





















ation. The genes significantly regulated between freshly isolated
Sdc4−/− mice were plotted as a Venn diagram to identify genes
ange). A heat map depicting changes in relative expression of genes
pts decreasing during the first 12 h following satellite cell activation
equency of genes that decrease (■) more than four-fold (22) is
n four-fold (22) during the first 12 h post-muscle injury (C). Further
genuity.com) demonstrate that genes promoting cell cycle
tion decrease (red) in wild type satellite cells 12 h post-muscle injury




















































Figure 3 Binding genes are enriched during satellite cell activation. Gene expression changes unique to wild type satellite cells occurring
within 12 h post-muscle injury were further analyzed by gene ontology. The general Molecular Function GO categories of Binding (P= 7.03 × 10-43),
Structural molecule activity (P= 4.97 × 10-4), Catalytic activity (P= 1.46 × 10-3), Transcription regulator activity (P= 0.0229), and Enzyme regulator
activity (P= 0.0521) were identified by DAVID as enriched when comparing satellite cells isolated 12 h post-muscle injury to freshly isolated satellite
cells (A). Specific Molecular Function GO terms including RNA binding, unfolded protein binding, and actin binding were enriched an average
of 1.5-fold when comparing satellite cells from injured and uninjured muscle as identified by three independent algorithms including
ProfCom, FunNet, and DAVID (B). The dotted line marks a 1.5-fold enrichment threshold. Asterisks mark GO terms with an average
enrichment≥ 1.5-fold.
Farina et al. Skeletal Muscle 2012, 2:21 Page 6 of 21
http://www.skeletalmusclejournal.com/content/2/1/216-month-old female B6D2F1/J mice were dissected and
digested in 400 U/mL collagenase in Ham’s F-12C at 37°C
for 1 h with periodic vortexing. The collagenase was
inactivated with horse serum and debris was removed
with sequential straining through 70 μm and 40 μm cell
strainers (BD Falcon). Satellite cells were either isolated
at the interface of a 40%/70% percoll gradient (GE
Healthcare) or plated in Ham’s F-12C supplemented withTable 2 Identified Molecular Function GO terms
GO Term DAVID P value
Unfolded protein binding 2.27 2.74E-05
Actin binding 1.83 2.00E-09
RNA binding 1.30 3.25E-04
Kinase activity 1.25 7.15E-04
Protein binding 1.25 8.42E-29
Nucleic acid binding 1.13 2.38E-04
Nucleotide binding 1.21 6.45E-07
Zinc ion binding 1.19 1.83E-05
Metal ion binding 1.17 7.66E-09
Fold enrichment and associated p-values for the Molecular Function GO terms shar
david.abcc.ncifcrf.gov), profcom (http://webclu.bio.wzw.tum.de/profcom/), and FunN15% horse serum and 0.5nM FGF-2 for various times
before RNA isolation.
miRNA inhibition
Myofiber explant cultures were transfected using Lipo-
fectamine 2000 (Invitrogen) according to manufac-
turer’s protocol with a 2.5:1 ratio of lipofectamine:
nucleic acid. 200nM miRIDIAN hairpin inhibitorsProfCom P value FunNet P value
4.65 2.90E-08 2.83 2.64E-08
2.60 2.10E-12 1.92 5.03E-10
1.82 9.80E-10 1.39 6.98E-05
1.54 4.30E-08 1.31 1.48E-04
1.52 5.90E-70 1.30 1.86E-21
1.63 7.50E-10 1.31 7.34E-05
1.50 6.10E-18 1.23 2.76E-06
1.38 1.80E-15 1.23 5.01E-05
1.37 5.20E-23 1.16 4.83E-05
ed between three independent gene ontological analyses using DAVID (http://
et (http://www.funnet.info).
Farina et al. Skeletal Muscle 2012, 2:21 Page 7 of 21
http://www.skeletalmusclejournal.com/content/2/1/21(Dharmacon) against miR-16, miR-93, miR-106b, and
miR-124 were co-transfected with pEGFP-C1-H2B.
Scrambled control was the miRIDIAN hairpin inhibitor
negative control 1 (Dharmacon).
Results
Identification of gene expression changes associated with
satellite cell activation in vivo
An unbiased global gene expression analysis using Affy-
metrix GeneChips was performed to identify changes oc-
curring during the transition of satellite cells from
quiescence to a population of proliferating myoblasts
in vivo. To accomplish this, we identified changes in gene
expression profiles between freshly isolated satellite cells
and satellite cells isolated 12 h or 48 h following BaCl2-
induced muscle injury. The time points chosen corres-
pond to activated satellite cells which do not express
MyoD protein (freshly isolated), committed myoblasts
marked by MyoD expression (12 h post-muscle injury),
and proliferating myoblasts (48 h post-muscle injury;
Figure 1A) [36,37]. Syndecan-4 null satellite cells fail toTable 3 Top 25 ranking biological interaction networks enrich
Rank Associated network function
1 RNA post-transcriptional modification, developmental
2 Genetic disorder, neurological disease, psychological d
3 Genetic disorder, cellular assembly and organization, s
4 Lipid metabolism, small molecule biochemistry, vitam
5 Nervous system development and function, tissue mo
6 Genetic disorder, metabolic disease, molecular transpo
7 Cell morphology, cell-to-cell signaling and interaction,
8 Genetic disorder, ophthalmic disease, cardiovascular d
9 Post-translational modification, cardiovascular disease,
10 Amino acid metabolism, genetic disorder, metabolic d
11 Cardiovascular system development and function, cell
12 Dermatological diseases and conditions, genetic disor
13 Organismal functions, cardiac stenosis, cardiovascular
14 Cellular assembly and organization, RNA post-transcrip
15 Carbohydrate metabolism, drug metabolism, nucleic a
16 Gene expression, amino ccid metabolism, small molec
17 Cell cycle, reproductive system development and func
18 Genetic disorder, neurological disease, psychological d
19 Cancer, cellular assembly and organization, cellular co
20 Cell cycle, cell death, cell morphology
21 Genetic disorder, metabolic disease, neurological disea
22 Post-translational modification, protein degradation, p
23 Cell signaling, cardiovascular disease, skeletal and mus
24 Lipid metabolism, small molecule biochemistry, derma
25 Cellular development, genetic disorder, hematological
The most significantly enriched biological networks during satellite cell activation w
com). The score is the negative base-10 logarithm of the P value (that is, a score ofactivate, express MyoD, or enter the cell cycle appropri-
ately within 48 h post-injury, and are incapable of skeletal
muscle repair (Figure 1B) [36,37]. Therefore, we elimi-
nated the genes whose expression changes following a
muscle injury in Sdc4−/− satellite cells from our analyses
as these genes were unlikely to be involved in satellite
cell activation. Wild type and Sdc4−/− satellite cells were
isolated by fluorescence activated cell sorting (FACS)
using anti-syndecan-3 antibodies as a marker for quies-
cent and proliferating satellite cells [38] from uninjured
tibialis anterior (TA) muscle (Figure 1C) and TA mus-
cles 12 h post-injury (Figure 1D).
RNA was extracted from the isolated cells and pro-
cessed for hybridization to Affymetrix v2.0 mouse Gene-
Chips. The GeneChip data (Additional file 1, Additional
file 2, Additional file 3, Additional file 4, Additional file 5,
Additional file 6) were analyzed with SpotfireTM Decision-
Site for Microarry Analysis software and an initial hier-
archical cluster dendrogram generated. Visualization of
the relationships between gene expression profiles show
Sdc4−/− samples, regardless of time post-injury, clustered during satellite cell activation
Score
disorder, genetic disorder 34
isorders 34
keletal and muscular disorders 34
in and mineral metabolism 32
rphology, cellular development 32
rt 32
cellular assembly and organization 32
isease 32
cardiovascular system development and function 32
isease 32
morphology, cell-to-cell signaling and interaction 32
der, amino acid metabolism 32
disease 32
tional modification, cancer 32
cid metabolism 32
ule biochemistry 32






cular system development and function 29
tological diseases and conditions 29
system development and function 29
ere generated through the use of IPA 9.0 (Ingenuity Systems, www.ingenuity.
34 is P≤ 10-34).
Table 4 Genes in the top ranked network associate with
muscle function, muscle disease, or fate determination
Genes Relevant role/Disease/Expression Reference
Luc7l Regulation of muscle differentiation [45]
Snrpn Prader-Willi syndrome [46]
Polr2a Positive regulation of embryonic stem cells [47]
Htatsf1 Expression in developing limb bud [48]
Zbtb3 Expression in developing limb bud [48]
Supt5h Expression in developing limb bud [48]
Tcerg1 Expression in developing limb bud [48]
Pqbp1 Facilitates neuronal proliferation and maturation;
Expression in developing limb bud
[48,49]
Snrpb Spinal muscular atrophy; Expression in
developing limb bud and somite
[7,48]
Snrpa1 Spinal muscular atrophy [50]
Syncrip Spinal muscular atrophy [50]
Sf1 Expression in developing limb bud [48]
AP3D1 Regulation of progenitor cell competence [51]
Hnrnpr Expression in developing limb bud [48]
Fourteen of the thirty-five genes in the top ranked biological network as
identified by IPA v9.0 (IngenuityW Systems, www.ingenuity.com) have defined
functions in muscle or cell fate determination as determined with the
associated references.
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supporting our observations that Sdc4−/− satellite cells
do not activate appropriately within 48 h following an
induced muscle injury (Figure 1A, B). Within the wild
type dataset, we observed that committed myoblasts iso-
lated 12 h post-injury exhibited the most divergent gene
expression profiles, suggesting that these committed sat-
ellite cells differ substantially from either quiescent satel-
lite cells or proliferating myoblasts (Figure 1E). To focus
on genes that may be involved in satellite cell activation,
we chose to further compare gene expression changes
occurring within the first 12 h post-muscle injury.
Over 4,000 genes are specifically regulated during
satellite cell activation
A comparative analysis of gene expression profiles from
wild type and Sdc4−/− satellite cells within the first 12 h
following satellite cell activation identified a cohort of
genes unique to satellite cell activation. In wild type
satellite cells, 5,162 genes change significantly between
satellite cells isolated from uninjured muscle and those
isolated 12 h post-injury as defined by a ≥ 2-fold change
with an ANOVA P ≤ 0.01 (Figure 2A). In contrast,
2,236 genes similarly changed expression in Sdc4−/−
satellite cells isolated from uninjured TA muscle and
TA muscles 12 h post-injury (Figure 2A). Eighty per-
cent (4,093) of the genes differentially expressed in
WT satellite cells do not significantly change in Sdc4−/−
satellite cells as identified by Venn analysis (Figure 2A,
B; Additional file 7). We reasoned that the metabolicchanges occurring during satellite cell activation as well
as the induction of the transcription factor MyoD and
cell cycle entry would result in a large cohort of induced
genes. Surprisingly, more than half (56%) of the genes
differentially expressed in satellite cells by 12 h post-
injury decrease in relative expression (Figure 2B).
Moreover, the magnitude of change for genes that de-
crease is on average three-fold greater than the mag-
nitude of change for genes that increase following
muscle injury. Less than 10% of genes whose expres-
sion is increased change more than four-fold (22),
while 70% of downregulated genes change more than
four-fold (22) and 3% decrease more than 64-fold (26)
(Figure 2C). These observations suggest that quiescent
satellite cells express a cohort of genes that maintains
and regulates the quiescent state, are likely critical for
interaction with the satellite cell niche, and are necessary
for interpreting signals for exit from quiescence. Further-
more, our results support the idea that satellite cell qui-
escence is actively maintained, consistent with a prior
report examining freshly isolated satellite cells and satel-
lite cells isolated from dystrophic muscle [14].
To further test the idea that satellite cell quiescence is
actively maintained, we analyzed genes in the cohort that
significantly change 12 h post-injury involved in cell
cycle progression. We would expect cell cycle progression
genes to be induced during activation and found that
genes modulating the G1/S phase transition are among
those that increase in relative expression (Figure 2D,
green). In contrast, cell cycle inhibitors decrease in relative
expression (Figure 2D, red) as expected for the transition
of satellite cells from mitotic quiescence to an activated
state in preparation for cell cycle entry. Moreover, these
genes do not change expression significantly in Sdc4−/−
satellite cells 12 h post-injury (Figure 2A, B; Additional file
7) consistent with their impaired cell cycle activation and
MyoD induction.
Genes involved in RNA post-transcriptional regulation are
significantly enriched during satellite cell activation
Gene ontology (GO) classifications were used to aid in
identifying potential mechanisms regulating satellite cell
activation. The Database for Annotation, Visualization
and Integrated Discovery (DAVID) was used to identify
enrichment of general molecular function categories
[39,40] during activation of satellite cells. The GO cat-
egory of Molecular Function: Binding is the most signifi-
cantly over-represented GO category during satellite cell
activation (P value = 7.03 × 10-43 compared to the mouse
genome), where a 7% increase in the total percentage of
genes classified as binding occurs in satellite cells within
the first 12 h post-muscle injury (Figure 3A). Further
refinement of ontological categories reveals that GO
terms unfolded protein binding, actin binding, and
Farina et al. Skeletal Muscle 2012, 2:21 Page 9 of 21
http://www.skeletalmusclejournal.com/content/2/1/21RNA binding were enriched an average of 1.5-fold over
three independent gene annotation algorithms: FunNet
[41,42], ProfCom [43], and DAVID [39,40] (Figure 3B,
Table 2). Thus, in the first 12 h post-muscle injury,
major changes occur in genes involved in RNA binding,
the unfolded protein response, and in actin binding.
The changes in RNA binding proteins and unfolded
protein response may be involved in the down-
regulation of genes necessary to maintain a quiescent
satellite cell, while changes in actin binding are likely to
reflect changes in satellite cell motility [44] that accom-
pany repair of skeletal muscle tissue.
A fourth independent analysis focused on biological net-
works (IPA-Ingenuity Pathway Analysis www.ingenuity.
com) ranked RNA Post-Transcriptional Modification in
the top biological network (Table 3; Table 4). Thus, from
four independent methods of gene expression analysis, a
much higher proportion of genes involved in post-
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develop hypotheses regarding the function of these genes
in the transition of satellite cells from mitotic quiescence
to cell cycle entry.
Splicing factors are preferentially downregulated during
satellite cell activation
The top ranking biological network identified by IPA has
associated biological functions of RNA Post-Transcriptional
Modification, Developmental Disorder, and Genetic Dis-
order (Table 3), where RNA Post-Transcriptional Modifica-
tion includes mRNA decay and stabilization, mRNA
splicing, and miRNA-mediated gene silencing. When we
examined genes within this network, nearly half of
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Figure 5 Classification of top quartile RNA binding proteins significantly regulated 12 h post-injury in satellite cells. Genes categorized
with the GO term Molecular Function: RNA Binding that change expression≥ two-fold (ANOVA P≤ 0.01) comprise 22% (154 of 716) of the total
GO category in wild type satellite cells but do not change significantly in Sdc4−/− satellite cell during the first 12 h post-muscle injury (A). A
minority of the identified genes increase in relative expression (B), while the majority of these genes decrease in their relative expression 12 h
post-muscle injury (C). Upregulated and downregulated genes were further classified and plotted as splicing factors (green bars), positive mRNA
regulators (blue bars), negative mRNA regulators (red bars), or multiple/other functions (black bars). The values plotted are for fold increase (B) or
fold decrease (C )unique to wild type satellite cells occurring in the first 12 h post-muscle injury.
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Table 5 Microarray and qPCR expression trends correlate for RNA binding proteins
Gene Microarray qPCR Fold change Correlation Biological function
Celf4 " " 2.51 Yes Splicing factor
Pabpn1 # # −1.80 Yes Positive mRNA regulator
Ppargc1a " " 1.34 Yes Positive mRNA regulator
Mbnl1 # # −1.14 Yes Splicing factor
Matr3 # " 11.79 No Negative mRNA regulator
Sfrs3 # " 19.11 No Splicing factor
Zfp36 # # −2.87 Yes Negative mRNA regulator
Zfp36l1 # # −4.48 Yes Negative mRNA regulator
Zfp36l2 # # −1.63 Yes Negative mRNA regulator
Elavl1 " " 3.01 Yes Positive mRNA regulator
Cdk2 " " 10.28 Yes Promotes cell cycle entry
E2F3 " " 12.90 Yes Promotes cell cycle entry
Eight of ten RNA binding proteins and two cell cycle genes validate expression changes between wild type satellite cells isolated from uninjured TA muscle and
from the TA 12 h post-muscle injury. Arrows show increase (") and decrease (#) for both microarray and qPCR during satellite cell activation. Fold change is from
qPCR data where positive values indicate increased expression and negative valued indicate decreased expression between satellite cells isolated from uninjured
TA muscle and from the TA 12 h post-muscle injury. Quantitative PCR data is normalized to GAPDH or 18S.
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splicing (Figure 4). Moreover, many genes in this
interaction network are implicated in either muscle
function, muscle disease, or cell fate decisions
(Table 4). Consistent with our prior observations that
downregulated genes exhibit greater fold change in
relative expression occurring during the first 12 h
post-muscle injury, the majority of RNA processing
and splicing genes identified in the interaction net-
work (87% and 88%, respectively) decrease post-
muscle injury (Figure 4). Furthermore, of the 154
RNA binding proteins identified by GO analysis
(Figure 3B, Additional file 8), 69% decrease in relative
expression (Figure 5A; Additional file 8). These data
show that RNA binding proteins are highly over-
represented in quiescent satellite cells and suggest
that regulation of RNA plays an important role in
maintaining the quiescent state and in the transition
to a cycling myoblast.
An examination of the top quartile of RNA binding
proteins with the most significant changes in expression
reveal that the majority (45%) of upregulated genes are
positive mRNA regulators (Figure 5B), while downregu-
lated genes include a similar distribution of all RNA pro-
tein functions with splicing factors exhibiting a slight
majority (37%: Figure 5C). Furthermore, 24% of the pre-
viously identified RNA processing of splicing factors
(Figure 4) are present in this top quartile. To confirm
the microarray expression data, we performed qPCR val-
idation finding that approximately 80% of the tested
RNA binding proteins and both tested cell cycle regula-
tors have consistent gene expression profiles (Table 5).
Thus, genes involved in mRNA regulation may playdiverse roles in satellite cell activation and promote the
conversion of a quiescent satellite cell to a proliferating
myoblast.
Dynamic regulation of miRNAs during muscle
regeneration
MicroRNA-mediated gene silencing regulates alternative
splicing [52,53] as well as mRNA stability factors
[54,55]. Moreover, miRNAs regulate stem cell fate deter-
mination [28,30,31,56] suggesting a potential role for
miRNAs in the transition of quiescent satellite cells to
proliferating myoblasts. The low levels of RNA present
in quiescent satellite cells combined with infrequent sat-
ellite cell abundance in uninjured muscle prevented suc-
cessful unbiased screen for miRNAs. Therefore, we
assessed whether genes involved in miRNA biogenesis
and gene silencing including argonautes1-4 (Eif2c1-4),
Dgcr8, and Dicer, as well as other genes associated with
miRNA function, are expressed in quiescent satellite cell
(Additional file 1, Additional file 2, Additional file 3,
Additional file 4, Additional file 5, Additional file 6). Al-
though present, Argonautes1-4 (Eif2c1-4), Dgcr8, and
Dicer are not in the cohort of differentially expressed
genes (Additional file 7), suggesting that major changes
in miRNA processing do not occur during satellite cell
activation.
To identify potential miRNAs involved in the transi-
tion of quiescent satellite cells to proliferating myoblasts,
we applied miRNA target prediction algorithms to iden-
tify putative miRNAs regulating genes whose expression
changes rapidly during the first 48 h post-muscle injury.
Initially, we established a minimum gene expression
value in freshly isolated satellite cells to reduce the
Table 6 Genes used to predict candidate miRNAs
Probe set ID Gene symbol Entrez gene Fold change
1417654_at Sdc4 20971 11.68
1418282_x_at Serpina1b 20701 6.78
1418510_s_at Fbxo8 50753 4.74
1419070_at Cys1 12879 3.78
1419302_at Heyl 56198 3.26
1420930_s_at Ctnnal1 54366 2.71
1420980_at Pak1 18479 3.13
1422889_at Pcdh18 73173 4.72
1422892_s_at H2-Ea 14968 25.61
1424559_at Rpap2 231571 5.15
1425336_x_at H2-K1 14972 34.35
1425609_at Ncf1 17969 2.68
1426981_at Pcsk6 18553 3.38
1427884_at Col3a1 12825 12.29
1429021_at Epha4 13838 3.51
1430764_at 1700023F06Rik 69441 3.12
1433639_at 5730593F17Rik 215512 3.30
1434105_at Epm2aip1 77781 2.91
1434267_at Nek1 18004 2.90
1434790_a_at Lta4h 16993 4.96
1435603_at Sned1 208777 3.12
1437152_at Mex3b 108797 4.08
1438532_at Hmcn1 545370 6.09
1438577_at — — 5.66
1439618_at Pde10a 23984 3.37
1440237_at Ercc4 50505 3.40
1441958_s_at Ager 11596 7.06
1442700_at Pde4b 18578 11.21
1444409_at Rph3al 380714 3.92
1444517_at — — 3.13
1447257_at — — 2.45
1447657_s_at Synpo2l 68760 3.00
1449226_at Hic1 15248 3.11
1449465_at Reln 19699 5.95
1449619_s_at Arhgap9 216445 3.20
1451513_x_at Serpina1a 20700 4.62
1452632_at Aak1 269774 3.64
1452896_at Gtl3 14894 8.40
1453114_at Nol9 74035 2.30
1453771_at Gulp1 70676 5.06
1454112_a_at Cep27 66296 2.46
1454433_at 6330526H18Rik 76174 2.95
1454877_at Sertad4 214791 6.96
1455136_at Atp1a2 98660 6.60
1455188_at Ephb1 270190 3.37
Table 6 Genes used to predict candidate miRNAs
(Continued)
1457944_at — — 16.23
1459164_at AU014678 101228 2.34
The relative expression data for genes that significantly change (ANOVA
P≤ 0.01, ≥ two-fold change) in wild type satellite cells isolated from
uninjured TA muscle or from the TA 48 h post-muscle injury and not in
Sdc4−/− satellite cells (ANOVA P> 0.9) is represented as a log2 values. Gene
identifiers are Probe set ID, representative gene symbol, and entrez gene ID.
The fold change was calculated for changes occurring in the first 12 h post-
muscle injury according to genotype.
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increased or decreased by ≥ two-fold during the first
48 h following muscle injury. As gene expression levels
did not change for 47 of these genes in Sdc4−/− satellite
cells (ANOVA P ≥ 0.9), we chose these 47 genes to pur-
sue as potential miRNA targets involved in satellite cell
activation (Table 6). Candidate miRNAs were then com-
putationally identified using two independent algo-
rithms, one developed by the group of Deepak
Srivastava (unpublished) and GeneAct (http://promoter.
colorado.edu/geneact/) [57] (Figure 6A). The union of
both algorithms identified 12 miRNA candidates with
six, miR-16, miR-93, miR-106b, miR-107, miR-124, and
miR-200b, being detected in cultured primary satellite
cells or proliferating satellite cell derived MM14 cells by
ribonuclease protection assay (Table 7). All six miRNAs
present in primary myoblasts and MM14 cells were de-
tectable in uninjured tibialis anterior muscle (Figure 6B).
We observed dramatic regulation of these six miRNAs
following a muscle injury when compared to control, un-
injured tibialis anterior muscle. Four of the identified
miRNAs (miR-93, miR-107, miR-124, and miR-200b)
changed expression levels by more than two-fold during
the first 5 days following induced muscle injury
(Figure 6B-F; Table 8). In the uninjured TA muscle, miR-
200b decreased three-fold by 12 h post-injury, while
miR-93 and miR-124 increased significantly 12 h post-
muscle injury (Figure 6B, C, F; Table 8). Within 48 h
post-injury, the relative levels of miR-93, miR-107, and
miR-124 had decreased levels well below those present in
uninjured muscle and remained low at 5 days post-injury
(Figure 6C-E). In contrast, miR-106b remained elevated
following injury while miR-16 trended to slightly lower
expression (Figure 6B-E). The rapid changes in miRNA
relative expression and their presence in skeletal muscle
suggest that these miRNAs may play important roles in
the regeneration of skeletal muscle and validates our
approach to identify such miRNAs.
Relative expression of miRNAs in satellite cells following
muscle injury
We asked whether the six miRNAs that change expres-
sion during muscle regeneration are present in satellite
cells, muscle tissue, or both. The relative expression
47 Filtered Genes















Priority 1, Priority 2
AND
GeneAct Prediction















































TA 5d Post Injury





















































































































































J Satellite  Cells
Figure 6 (See legend on next page.)
Farina et al. Skeletal Muscle 2012, 2:21 Page 13 of 21
http://www.skeletalmusclejournal.com/content/2/1/21
(See figure on previous page.)
Figure 6 Screening and characterization of candidate miRNAs with dynamic expression patterns during muscle regeneration.
A combinatorial screen was used to identify miRNAs from potential target genes that uniquely change expression in wild type satellite cells
following a muscle injury. Gene expression changes of≥ two-fold, P≤ 0.01 occurring in wild type satellite cells 48 h post-muscle injury compared
to freshly isolated satellite cells that changed≤ two.0-fold, P≥ 0.9 in syndecan-4 null cells yielded 47 genes (Table 6) that were subjected to the
flow schematic to identify potential miRNAs (A). The union from both algorithms yielded 12 candidate miRNAs, six of which were detectable by
RNase protection assay in cultured satellite cells or the satellite cell derived MM14 cell line in growth or differentiation conditions (Table 7). These
six miRNAs are expressed in uninjured skeletal muscle (B) and four of the six change expression dynamically during skeletal muscle regeneration
at 12 h (C, F), 48 h (D, F) and 5d (E, F) post-muscle injury. The same four micro RNAs (miR-16, miR-93, miR-106b, and miR-124) exhibit dynamic
changes in relative expression when comparing activated satellite cells (G, J) to proliferating satellite cells (H, J) and quiescent satellite cells (I, J).
All qPCR data was normalized to U6 RNA. miRNA levels in uninjured TA muscle were set to 1 (y-axis). Values above the y-axis indicate higher
miRNA expression than in uninjured TA muscle and values below the y-axis indicate lower miRNA expression than in uninjured TA muscle (C-J).
Graphs B-E and G-I are log scale and values are mean± SEM (n= 3). Graphs F and J are average fold difference as compared to relative expression
in B.
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muscle was normalized to 1 and the relative levels in sat-
ellite cells isolated from uninjured muscle and in prolif-
erating satellite cells isolated 48 h post-injury examined.
Surprisingly, all six miRNAs were expressed at low to
undetectable levels in freshly isolated satellite cells
(Figure 6G). In proliferating satellite cells, all but miR-
106b were expressed at levels substantially lower than
that found in the tibialis anterior muscle (Figure 6H).
Although MyoD protein is not detectable in freshly iso-
lated satellite cells and they have not yet entered S-
phase, freshly isolated satellite cells are not quiescent
since the p38α/β MAPK is activated [8]. Therefore, to
identify miRNAs present in quiescent satellite cells, mice
were injected with SB203580, a p38α/β MAPK inhibitor,
1.5 h prior to satellite cell isolation (Hausburg et al.,
Submitted), and relative miRNA levels examined. Re-
markably, we found that miR-124 was expressed 35-fold
higher in quiescent satellite cells than in freshly isolated
or proliferating satellite cells (Figure 6I, J; Table 8).
Moreover, miR-124 was expressed at levels 10-fold
greater in quiescent satellite cells than in uninjured skel-
etal muscle (compare Figure 6I and 6B, Figure 6J;
Table 8), suggesting that the primary source of miR-124
in uninjured muscle is the satellite cell population. In
contrast to miR-124, miR-16 and miR-93 are present at
low to undetectable levels in quiescent satellite cells and
are induced in freshly isolated satellite cells (Figure 6G,
I). The expression level of miR-16 is maintained in pro-
liferating cells, while miR-93 declines and miR-106b is
dramatically induced in proliferating satellite cells as
compared to freshly isolated and quiescent satellite cells
(Figure 6G-I).
miR-16, miR-106b, and miR-124 regulate satellite cell fate
The changes in relative levels of miR-16, miR-93, miR-
106b, and miR-124 in satellite cells following a muscle
injury suggests that these four miRNAs may play arole in the transition from a quiescent satellite cell to
a proliferating myoblast. To test this idea, inhibitors
for each miRNA were transfected into myofiber-
associated satellite cells immediately following isolation
and the cultures fixed and assayed at 3 days post-
isolation and 5 days post-isolation. The total number
of Pax7+ cells transfected with the scrambled RNA
control inhibitor declined two-fold between 3 and 5 days
in culture, indicative of differentiation (Figure 7A, B). Be-
tween 3 and 5 days in culture, the Pax7+/MyoD+
decreased three-fold accompanied by the appearance of
the Pax7+/MyoD- ‘reserve’ population (Figure 7C-F). In
contrast, inhibition of miR-124 increased the percentage
of Pax7+/MyoD- ‘reserve’ cells at 3 and 5 days of culture,
as did inhibition of miR-106b (Figure 7A-F). Inhibition of
miR-16 elevated the total number of Pax7+ cells at 5 days
of culture and inhibition of miR-93 did not have any de-
tectable effect (Figure 7-F). We further examined the role
of miRNAs in satellite cell activation using IngenuityW
System’s IPA and identified PTEN signaling and Cell
Cycle Regulation by BTG Family Proteins as the top ca-
nonical pathway regulated by miR-16, miR-93, miR-106b,
and miR-124 in the transition of a quiescent satellite cell
to a proliferating myoblasts (Figure 8). Many predicted
targets of miR-16 and the miR-93/106b family inhibit cell
cycle progression and cell growth. These targets are
downregulated during satellite cell activation, consistent
with increased expression of miR-16, miR-93, and miR-
106b in proliferating satellite cells as compared to quies-
cent satellite cells (Figure 8). Conversely, predicted target
genes of miR-124 promote cell cycle progression and are
upregulated during satellite cell activation when miR-124
is downregulated (Figure 8). These data demonstrate that
a number of miRNAs regulate satellite cell fate following
a muscle injury and support the idea that post-
transcriptional regulation of RNA plays a critical role in
satellite cell activation and maintenance of satellite cell
quiescence.
Table 7 Six of twelve predicted miRNAs are expressed in
satellite cells
miRNA Rationale Detected in SCs
miR-16 Priority 2 and GeneAct +
miR-26a/b Priority 1 and GeneAct ND
miR-30a Priority 1, 2 and GeneAct -
miR-93 Priority 1 and GeneAct +
miR-106b Priority 1 and GeneAct +
miR-107 Priority 2 and GeneAct +
miR-124 Priority 1 and GeneAct +
miR-130a Priority 1 and GeneAct -
miR-132 Priority 1 and GeneAct -
miR-200b Priority 1 and GeneAct +
miR-320 Priority 1 and GeneAct -
miR-424 Priority 1 and GeneAct -
We predicted 12 candidate miRNAs from 47 genes identified as only
expressed in satellite cells or only expressed in myoblasts. miR-16, miR-93,
miR-106b, miR-107, miR-124, and miR-200b are detected in satellite cells by
RNase protection assay in either primary satellite cells or in the satellite cell
derived MM14 cell line.
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The low cytoplasmic to nuclear ratio, low organelle
number, and mitotic quiescence of resident satellite cells
[12,13] lead to the speculation that metabolic activity in
these cells is low. Indeed, quiescent satellite cells with
high levels of Pax7 express reduced levels of mitochon-
drial genes [58]. Moreover, the delay to the first cell
cycle division (Troy et al.)a coupled with the dramatic
increase in cell size and mobility [36,44] suggests that
satellite cell activation and cell cycle entry would require
transcriptional induction of a large cohort of genes simi-
lar to that observed in serum stimulated fibroblasts [59].
However, we and others have postulated that quiescent
satellite cells are poised for activation awaiting a critical
signaling event [8,14]. The data presented here further
support this hypothesis and provide the first direct com-
parison of quiescent satellite cells with activated satellite
cells and proliferating myoblasts derived from uninjured
and injured skeletal muscle, respectively. The prior ana-
lyses performed compared freshly isolated satellite cells
with satellite cells isolated from dystrophic mice [14] orTable 8 Fold difference of candidate miRNAs as compared to
miR-16 miR-93
12 h PI −1.1 2.7
48 h PI −1.3 −3.5
5d PI −1.9 −2.0
Quiescent satellite cell −10.9 −3.9
Freshly isolated satellite cell −2.3 −1.6
Proliferating satellite cell −2.7 −6.8
Fold difference of miRNA expression as compared to resting muscle where positive
change; ND, not detected.cultured cells [14,34] and are expected to identify gene
expression changes associated with a diseased environ-
ment or a culture environment, respectively. Since the
most significant reductions in gene expression occur
within the first 12 h post-muscle injury, the metabolic
and signaling events in a quiescent satellite cell are thus
predicted to be divergent from those of a proliferating
myoblast. Moreover, these data suggest that comparisons
of freshly isolated satellite cells with proliferating myo-
blasts may not identify critical regulatory mechanisms
involved in satellite cell activation [14,34].
Here, we used computational methods to initially iden-
tify that RNA post-transcriptional mechanisms are likely
to maintain the quiescent satellite cell phenotype and to
promote the conversion of the quiescent satellite cell to a
transit-amplifying myoblast. Recent studies indicate that
RNA post-transcriptional mechanisms, specifically alter-
native splicing, mRNA stability, and miRNA-mediated
gene silencing, regulate stem cell pluripotency and pro-
gression through differentiation [17-20]. As satellite cells
are an adult stem cell population, similar mechanisms
may mediate the transition from quiescence to a popula-
tion of proliferating myoblasts. We found that splicing
factors may play roles in regulating the transition of sat-
ellite cells from quiescence to proliferating myoblasts.
Consistent with these observations, the relative molar
ratios of splicing factors guide alternative splicing [60]
and these factors often function combinatorially to direct
the expression of different mRNA splice variants [61].
Together with published data, our observations of dy-
namic splicing factor expression in satellite cells follow-
ing muscle injury suggests that unique cohorts of mRNA
species regulate the conversion of quiescent adult stem
cells to the committed proliferating myoblast.
In addition to splicing factors, we found that mRNA
binding proteins regulating mRNA stabilization and
mRNA decay are preferentially upregulated in satellite
cells following muscle injury. Indeed, the AU-rich elem-
ent (ARE) binding protein HuR (Elavl1) is reported to
stabilize MyoD and myogenin mRNA in skeletal muscle
cell lines derived from satellite cells [62,63] potentially
participating in satellite cell activation and commitmentlevels in resting muscle
miR-106b miR-107 miR-124 miR-200b
1.9 −1.9 3.4 −2.7
NC −6.8 −5.8 −12.4
1.7 −3.0 −3.1 −3.1
ND ND 7.4 ND
−24.3 −14.3 −10.3 −1418.2
1.1 −16.5 −4.8 −6.5































































































































































































































































































































































































Figure 7 Inhibition of candidate miRNAs alters satellite cell fate. The four candidate miRNAs (miR-16, miR-93, miR-106b, and miR-124) that
displayed dynamic expression in satellite cells were inhibited in myofiber-associated satellite cells prior to the first cell division. Transfected cells
were assessed 3 or 5 days post myofiber harvest and identified via immunofluorescence as satellite cells by Pax7 expression (A, B) with
proliferating satellite cells expressing both Pax7 and MyoD (C, D) and quiescent satellite cells expressing only Pax7 (E, F). The percent of Pax7+
satellite cells decreased between 3 and 5 days in satellite cell populations treated with a scrambled RNA control, however, the relative number of
Pax7+ satellite cells remained at similar levels when any candidate miRNA was inhibited (A, B). This increase in satellite cells following miRNA
inhibition at 5 days was observed in both proliferating satellite cells (D) and quiescent satellite cells (F) for miR-16, miR-106b, and miR-124 while
inhibition of miR-93 resulted in a specific increase in proliferating satellite cells at 5 days (D). Inhibition of two miRNAs, miR-106b and miR-124,
resulted in a dramatic increase in quiescent satellite cells by 3 days post myofiber isolation (E) that remains consistent through 5 days post
isolation (F).

































































1. Well-organized actin cytoskeleton
and focal contacts



















1. Short actin bundles
and fewer focal contacts





















Figure 8 (See legend on next page.)
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Figure 8 Candidate miRNAs target genes involved in cell growth, survival, migration, and cell cycle progression. The predicted target
genes of miR-16, miR-93, miR-106b, and miR-124 were identified using IngenuityW Systems (www.ingenuity.com). PTEN Signaling and Cell Cycle
Regulation by BTG Family Proteins emerged as the top ranked canonical pathway regulated during satellite cell activation. The pathways and
relative expression changes occurring during satellite cell activation are depicted. Note that the miRNAs have opposite expression profiles of their
respective target mRNAs. Red indicates mRNAs downregulated and green indicates mRNAs upregulated with the intensity of red or green
indicating increasing or decreasing fold change, respectively. The data compare mRNAs unique to wild type satellite cells isolated 12 h post-injury
to satellite cells isolated from uninjured skeletal muscle.
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upregulated RNA binding genes in satellite cells within
12 h of muscle injury (See Figure 5C; Additional file 8)
and corresponds to MyoD expression. Interestingly, the
ARE-binding proteins, tristetraprolin (Zfp36) and family
members Zfp36l1 and Zfp36l2, decrease dramatically
during the conversion from quiescence to activated sat-
ellite cells within the first 12 h post-muscle injury (See
Figure 5D; Additional file 8). However, tristetraprolin
and HuR have opposing functions as they counter-
regulate expression of the same mRNAs [64,65] and
may act as an agonist–antagonist pair for many genes
that promote commitment to myogenesis. In agreement
with these data, we have demonstrated that the Zfp36
family directly targets MyoD mRNA and functions to
regulate satellite cell fate during satellite cell activation
and self-renewal (Hausburg et al., Submitted).
A recent report identifies miR-489 as an important
miRNA maintaining satellite cell quiescence [32] suggest-
ing that miRNA-mediated gene silencing functions in the
transition of a quiescent satellite cell to a proliferating
myoblast. We identified a cohort of genes that signifi-
cantly change expression in satellite cells within the first
48 h following muscle injury to computationally predict
cognate miRNAs that may regulate these targets with two
independent prediction algorithms. Six miRNAs not pre-
viously reported in skeletal muscle were selected for fur-
ther analysis and all six were observed to be dynamically
regulated in relative levels during induced muscle injury.
Moreover, four of the six miRNAs were expressed in satel-
lite cells (miR-16, miR-93, miR-106b, and miR-124), while
two were likely present only in differentiated muscle
(miR-107 and miR-200b). Comparing relative levels in
muscle tissue and satellite cells revealed that miR-124 is
likely only expressed in satellite cells, while miR-16, miR-
93, and miR-106b are most likely expressed in satellite
cells and in differentiated muscle fibers. Pathways pre-
dicted to be targeted by these miRNAs include cell cycle
progression as well as PTEN signaling, which is involved in
stem cell self-renewal [66] and muscle regeneration [67].
To directly test whether these four miRNAs regulate
satellite cell behavior, we transfected inhibitors for each
miRNA into myofiber-associated satellite cells shortly
after isolation and examined the effects on satellite cell
fate at 3 and 5 days post-myofiber isolation. Inhibition oftwo miRNAs, miR-106b and miR-124, increased the rela-
tive number of progenitor or ‘reserve’ satellite cells (Pax7
+/MyoD-) relative to a control, suggesting that these miR-
NAs participate in the regulation of satellite cell fate and
satellite cell self-renewal. In contrast, miR-16 enhanced
the relative numbers of Pax7+ cells but did not appear to
alter the percentage of Pax7+/MyoD+myoblasts or Pax7
+/MyoD- ‘reserve’ cells relative to a scrambled control. Of
the four miRNAs tested, the loss of miR-93 elicited no de-
tectable changes in the numbers of ‘reserve’ Pax7
+/MyoD- satellite cells and Pax7+/MyoD+ satellite cells
suggesting functions in cellular processes other than cell
fate determination.
Conclusions
We believe that RNA post-transcriptional regulation plays
a critical role in the transition of a quiescent satellite cell
to a transit-amplifying myoblast. At each time point we
examined, including quiescent satellite cells (freshly iso-
lated in the presence of a p38α/β MAPK inhibitor), ac-
tivated satellite cells (12 h post-muscle injury), and
proliferating myoblasts (48 h post-muscle injury), we
found extensive changes in genes involved in post-
transcriptional RNA regulation, including mRNA splicing,
mRNA stability, and miRNA-mediated gene silencing. We
conclude that satellite cell quiescence is actively main-
tained via combinatorial contributions primarily mediated
through post transcriptional mRNA regulation and identi-
fied four miRNAs that likely play a role in the conversion
of quiescent satellite cells to proliferating myoblasts.
Endnotes
Following submission of our manuscript, the following
was published demonstrating post-transcriptional regula-
tion of myf-5 during satellite cells activation. Crist CG,
Montarras D, Buckingham M (2012) Muscle Satellite Cells
Are Primed for Myogenesis but Maintain Quiescence with
Sequestration of Myf5 mRNA Targeted by microRNA-31
in mRNP Granules. Cell Stem Cell 11: 118-126.
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uninjured muscle. Raw expression data for three replicates of satellite
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Additional file 2: CEL files of wild type satellite cells isolated 12 h
post-injury. Raw expression data for three replicates of satellite cells
isolated from wild type TA muscles 12 h post-injury. *. CEL files can be
opened with any microarray analysis software including the Affymetrix




Additional file 3: CEL files of wild type satellite cells isolated 48 h
post-injury. Raw expression data for three replicates of satellite cells
isolated from wild type TA muscles 12 h post-injury. *. CEL files can be
opened with any microarray analysis software including the Affymetrix




Additional file 4: CEL files of syndecan-4−/− satellite cells isolated
from uninjured muscle. Raw expression data for three replicates of
satellite cells isolated from syndecan-4−/− uninjured TA muscles. *. CEL
files can be opened with any microarray analysis software including the




Additional file 5: CEL files of syndecan-4−/− satellite cells isolated
12 h post-injury. Raw expression data for three replicates of satellite
cells isolated from syndecan-4−/− TA muscles 12 h post-injury. *. CEL files
can be opened with any microarray analysis software including the




Additional file 6: CEL files of syndecan-4−/− satellite cells isolated
48 h post-injury. Raw expression data for three replicates of satellite
cells isolated from syndecan-4−/− TA muscles 12 h post-injury. *. CEL files
can be opened with any microarray analysis software including the




Additional file 7: Satellite cell activation gene expression profile.
Excel spreadsheet (*.xlsx) with columns for probe set ID, log2
expression data, ANOVA P value, fold change, and gene ID for
unique genes that significantly change (ANOVA P≤ 0.01, ≥ two-fold
change) in WT and not in Sdc4−/− satellite cells 12 h after
BaCl2-induced injury. The ANOVA P value and fold change was
calculated for changes occurring in the first 12 h post-muscle injury
according to genotype.
Additional file 8: Molecular Function: RNA Binding genes regulated
during satellite cell activation. Excel spreadsheet (*.xlsx) of RNA
binding proteins from Additional file 7 with gene identifiers of Probe set
ID, representative gene symbol, and entrez gene ID. The relative
expression data for genes that significantly change (ANOVA
P≤ 0.01, ≥ two-fold change) in wild type and in Sdc4−/− satellite cells
isolated from uninjured TA muscle or from the TA 12 h post-muscle
injury is represented as a log2.Abbreviations
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